Shanghai Guoxin Investment, established in 2000, is an investment firm based in Shanghai, China. It functions as a corporate venture arm under Shanghai State-Owned Assets Operation Co. The firm focuses on making investments across various sectors, including consumption, healthcare, and advanced manufacturing, aiming to support growth and innovation within these industries.
Metaways specializes in the development, design, and manufacturing of micro OLED display devices and modules, primarily serving the augmented and virtual reality (AR/VR) markets. The company operates a 12-inch silicon-based Micro OLED production line and boasts a comprehensive team with expertise in IC design and microdisplay packaging, ensuring high-quality products for clients.
Fourier Intelligence
Series E in 2025
Fourier Intelligence is a Shanghai-based technology and design company that specializes in the development of exoskeleton robotic products and services aimed at rehabilitation and orthoses. The company offers advanced robotics technology, including upper-limb rehabilitation robotics and lower-limb exoskeletons, which assist individuals with disabilities in overcoming physical limitations, enabling them to stand and walk again. Its innovative products not only enhance the quality of life for users but also improve productivity by reducing fatigue and facilitating the transportation of heavy objects in various sectors. Fourier Intelligence is committed to advancing healthcare and rehabilitation through its pioneering technologies, empowering individuals to regain mobility and independence.
RUICYCLE
Series C in 2024
RUICYCLE is a high-tech company dedicated to the comprehensive recycling and utilization of lithium batteries. The company specializes in developing solutions for lithium battery recovery, encompassing cascade utilization, material regeneration, and new material recycling. RUICYCLE's innovative technologies offer industry users a closed-loop ecosystem that emphasizes automatic safe crushing and environmentally friendly treatment processes. By focusing on zero pollution and efficient recycling, RUICYCLE aims to address the challenges associated with lithium battery waste and contribute to sustainable practices in the industry.
Super Silicon Semiconductor
Series C in 2024
Super Silicon Semiconductor focuses on the research and development of parts and materials for silicon integrated circuits.
Calterah
Series D in 2024
Calterah specializes in the development of CMOS single-chip millimeter-wave radar sensors aimed at automotive applications. The company produces system-on-chip (SoC) products that integrate radar signal processing baseband technology, facilitating the design and implementation of mmWave radar sensors. These sensors find applications in various sectors, including both industrial and consumer markets, supporting technologies related to environmental sensing, autonomous obstacle avoidance, and radar imaging. Calterah's innovations contribute significantly to advancements in autonomous driving and related technologies.
Systech
Series B in 2024
Systech is an electroplating equipment manufacturing company. It manufactures all electroplating and chemical plating equipments.
Sinovent
Series E in 2024
Sinovent Inc., established in 2016, is a global biopharmaceutical company with headquarters in Suzhou, China, and additional offices in Beijing, China, and Boston, U.S.A. The company specializes in developing advanced treatments for global healthcare challenges, with a focus on oncology, autoimmune diseases, and infectious diseases. Sinovent's portfolio comprises 12 products in development, leveraging its expertise in science, management, and finance, and commitment to global standard excellence through its advanced biotechnology platform.
Kai Medtech
Series C in 2024
Kai Medtech is a company focused on the development and supply of medical devices aimed at treating cerebrovascular diseases. It operates within the vascular device industry and emphasizes research and development of neurointerventional medical devices. By utilizing a comprehensive research-production-marketing system, Kai Medtech seeks to enhance treatment options for patients suffering from cerebrovascular and neurological conditions. The company is committed to leveraging nerve intervention techniques as a primary approach to improve patient outcomes in this specialized field.
Triastek
Series C in 2023
Triastek Co. Ltd., established in 2015 and headquartered in Nanjing, China, specializes in the manufacturing of 3D printed pharmaceuticals and related medical equipment. The company offers a range of drugs, including blockbuster and orphan drugs, along with complex drug delivery technologies. Triastek's portfolio comprises drug 3D printing services, such as formulation design, 3D printing equipment, and drug product development methods, with patents secured in key global markets like China, the US, Europe, and Japan. Notably, Triastek owns the Melt Extrusion Deposition (MED) technology, a universally applicable 3D printing method for solid formulations. The company's mission is to revolutionize drug delivery, development, and manufacturing through its innovative 3D printing technology.
Joyintech
Venture Round in 2023
Joyintech is a company that creates asset management software for the financial industry. The company creates business management systems, asset management systems, and securitization systems for banks and other financial institutions, allowing its customers in the financial industry to manage their businesses digitally and efficiently.
GeneMind Biosciences
Series C in 2023
GeneMind Biosciences Company Limited, founded in 2012 and based in Shenzhen, China, specializes in the development and manufacturing of medical devices, particularly focusing on third-generation genome sequencing technology. This advanced technology enables noninvasive detection, disease diagnosis, and personalized treatment options. GeneMind aims to enhance gene sequencing solutions for clinicians and researchers, positioning its gene sequencer as a key asset in the field. The company's commitment to innovation is driven by ongoing research efforts to overcome challenges in gene sequencing, reflecting its dedication to advancing healthcare through improved diagnostic capabilities.
OptoMedic
Debt Financing in 2023
OptoMedic specializes in the research, development, and production of advanced optical medical devices and systems. The company focuses on creating medical fluorescence navigation endoscopes that utilize aerospace and military optical technology for applications in healthcare. Its product offerings include endoscopic monitoring equipment, cancer screening tools, endoscopic navigation systems, and fluorescent imaging systems. These innovations enable medical institutions and healthcare providers to effectively observe and assess patient conditions, enhancing diagnostic capabilities and treatment outcomes.
Xindi Digital Engineering System
Series D in 2023
Xindi Digital Engineering System specializes in the development of commercial software products for computer-aided design (CAD), focusing on 3D technology. The company creates CAD content compatible with a variety of systems, including AutoCAD, SolidWorks, CATIA, UG, Pro/E, Inventor, Solid Edge, Geomagic, Maya, and 3D Studio Max. By providing these solutions, Xindi enables manufacturing enterprises to efficiently establish comprehensive digital product development and design systems.
ZStack
Series C in 2023
ZStack is a provider of cloud computing services focused on making cloud technology more accessible for enterprises across various industries, including government, finance, education, and manufacturing. The company offers a range of solutions, including private and hybrid cloud systems, mini hyper-converged machines, and a cloud management platform. Additionally, ZStack provides enterprise-class distributed storage and other cloud-related products, enabling businesses to manage their data center resources—covering computing, networking, and storage—under a unified framework. With a client base of over 2,500 enterprise users, ZStack has also formed partnerships with more than 250 cloud vendors to enhance its ecosystem and channel offerings.
BociMed
Series B in 2023
BociMed is a company engaged in drug research and development and clinical research. Through the establishment of a standardized service system, it provides high-quality R&D and outsourcing services for drug discovery, preclinical pharmaceutical research and development, clinical I-IV trials and registration.Shanghai Bozhiyan New Drug Technology Co., Ltd. is a high-tech enterprise specializing in drug research and development technical services, Shanghai High-tech Enterprise, Shanghai Credit Creation Enterprise, and Shanghai Small and Medium Enterprise Innovation Undertaking Enterprise. The company started in 2007 and was formerly known as Shanghai Maibo Pharmaceutical Technology Co., Ltd., registered in Jinshan Petrochemical Zone, mainly engaged in raw material sales, drug import registration and regional cooperation development in China. In 2012,
Xi'an Triangle Defense
Post in 2023
Xi'an Triangle Defense Co., Ltd. is a research, development, and manufacturing firm based in Xi'an, China, specializing in precision forgings for both military and civilian applications. The company produces a range of products, including airplane structure parts, civil aircraft frames, landing gear, and integral structural components for aero-engines. Additionally, it manufactures engine discs and large to medium-sized die forgings. Xi'an Triangle Defense serves various industries, such as aviation, aerospace, maritime, defense, and nuclear sectors, both domestically and internationally.
BioInno
Series A in 2021
BioInno is a China-based company that specializes in biopharmaceutical contract development and manufacturing organization (CDMO) services. It focuses on process development and Good Manufacturing Practice (GMP) production for biotechnology and pharmaceutical companies seeking to introduce protein, cell therapy, and gene therapy drugs to both the Chinese and global markets. By offering comprehensive outsourcing solutions, BioInno supports clients in the complex development and production processes necessary for bringing innovative therapies to market.
Gerui Liye
Series C in 2021
Gerui Liye is an intelligent manufacturing solution service provider focusing on semiconductors with AI in manufacturing applications.
Yunying Medical
Venture Round in 2020
Yunying Medical specializes in gene mutation, methylation detection, and recombination solutions for cancer diagnosis and treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.